RADIANCE Continued Access Protocol (RADIANCE CAP): A study of the ReCor Medical Paradise System in Clinical Hypertension

Brief description of study

RADIANCE CAP is a non-randomized, 2-cohort study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System and to allow for the on-going collection of safety and effectiveness data in two populations of subjects with uncontrolled hypertension despite the prescription of antihypertensive medications.

Clinical Study Identifier: s22-01432
ClinicalTrials.gov Identifier: NCT05017935

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.